Clinical Trial Update: Intramuscular Ketorolac at Two Single-Dose Regimens [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating two single-dose regimens of intramuscular ketorolac for musculoskeletal pain/analgesia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Musculoskeletal Pain

Drugs mentioned

• Toradol (ketorolac tromethamine)

Snippet

Sponsor: William Beaumont Army Medical Center | Conditions: Musculoskeletal Pain, Analgesia | Phase 4 | Status: COMPLETED | Results posted: 2025-10-15